A practical nomogram based on serum interleukin-6 for the prognosis of liver failure
暂无分享,去创建一个
Y. Nie | Linxiang Liu | Yue Zhang | Xuan-jin Zhu | Na Xiao
[1] zhi-liang gao,et al. Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF , 2021, Canadian journal of gastroenterology & hepatology.
[2] W. Kim,et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021 .
[3] J. Lai,et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.
[4] G. D’Amico,et al. TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. , 2021, Journal of hepatology.
[5] W. Kim,et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.
[6] Meng Zheng,et al. UMSCs Attenuate LPS/D-GalN-induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway , 2021, Journal of clinical and translational hepatology.
[7] Roshan George,et al. Cystatin C and interleukin‐6 for prognosticating patients with acute decompensation of cirrhosis , 2021, JGH Open.
[8] J. Clària,et al. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure , 2020, Cells.
[9] Ning Zhang,et al. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure , 2020, World journal of gastroenterology.
[10] P. Galle,et al. Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy , 2019, Alimentary pharmacology & therapeutics.
[11] William M. Lee,et al. Acute liver failure , 2019, The Lancet.
[12] A. de Gottardi,et al. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis , 2019, Front. Immunol..
[13] Liver Failure. Guideline for diagnosis and treatment of liver failure , 2019 .
[14] Failure. Guideline for diagnosis and treatment of liver failure , 2018 .
[15] R. Moreau,et al. Cell death markers in patients with cirrhosis and acute decompensation , 2017, Hepatology.
[16] D. Harats,et al. Interleukin-1α and Interleukin-1β play a central role in the pathogenesis of fulminant hepatic failure in mice , 2017, PloS one.
[17] Jun Yu Li,et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure , 2017, Gut.
[18] T. Berg,et al. Increased Level of Interleukin 6 Associates With Increased 90‐Day and 1‐Year Mortality in Patients With End‐Stage Liver Disease , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[19] M. Bazzo,et al. From stable disease to acute‐on‐chronic liver failure: Circulating cytokines are related to prognosis in different stages of cirrhosis , 2017, Cytokine.
[20] Richard Moreau,et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.
[21] Ashok Choudhury,et al. Acute-on-chronic liver failure: terminology, mechanisms and management , 2016, Nature Reviews Gastroenterology &Hepatology.
[22] Lei Qu,et al. The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection , 2015, Medicine.
[23] Y. Li,et al. Comparison of Current Diagnostic Criteria for Acute-On-Chronic Liver Failure , 2015, PloS one.
[24] W. Kim,et al. Toward an improved definition of acute-on-chronic liver failure. , 2014, Gastroenterology.
[25] E. Christensen,et al. Cardiac and proinflammatory markers predict prognosis in cirrhosis , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[26] Uma Maheshwari,et al. Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End‐Stage Liver Disease (MELD) and King's College Hospital Criteria , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] L. Fainboim,et al. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. , 2016, Cytokine.